Bliss GVS Pharma share news, announcements and annual reports
NSE: BLISSGVSBSE: 506197Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹648.50.
29 Oct: open ₹667.95, high ₹680.90, low ₹652.75
- Under NSE's long-term additional surveillance, stage IV, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹7,240 Cr1,000th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 44.92
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.61
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.22%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 13.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 14.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 4,47,694
Bliss GVS Pharma has 628 announcements on record, routine notices left out; 8 in the 30 days to 30 Oct 2026, the latest on 29 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Bliss GVS Pharma quarterly results
The board met on 29 Oct 2026 to consider financial results and other business matters
Notice filed 22 Oct 2026
Bliss GVS Pharma annual reports, presentations and earnings calls
The company's own documents, latest first.Bliss GVS Pharma financials, year by year
Annual reports15
- Annual report, year to Mar 202623 Jun 2026
- Annual report, year to Mar 20259 Jul 2025
- Annual report, year to Mar 20243 Jul 2024
- Annual report, year to Mar 202327 Jun 2023, a zip file
- Annual report, year to Mar 20227 Sep 2022, a zip file
10 earlier reports
- Annual report, year to Mar 202128 Aug 2021, a zip file
- Annual report, year to Mar 20203 Sep 2020, a zip file
- Annual report, year to Mar 201927 Aug 2019, a zip file
- Annual report, year to Mar 201828 Aug 2018, a zip file
- Annual report, year to Mar 201728 Sep 2017, a zip file
- Annual report, year to Mar 201619 Sep 2016, a zip file
- Annual report, year to Mar 201514 Sep 2015, a zip file
- Annual report, year to Mar 201420 Aug 2014, a zip file
- Annual report, year to Mar 201322 Nov 2013, a zip file
- Annual report, year to Mar 201222 Oct 2013, a zip file
Investor presentations7
- Investor Presentation on Company's performance for the quarter ended June 30, 2019. Kindly take the same on record.21 Aug 2019
- Investor Presentation on Company's performance for the quarter and year ended March 31, 2019.21 May 2019
- Investor Presentation on Companys performance for the quarter and nine months ended December 31, 2018.1 Feb 2019
- Investor Presentation on Company's performance for the quarter and half year ended September 30, 2018.3 Nov 2018
- Investor Presentation on Financial Results of the Company for the quarter ended June 30, 20189 Aug 2018, a zip file
2 earlier presentations
- Bliss GVS Pharma - Earnings Presentation - Q4-FY1817 May 2018, a zip file
- Earning Presentation 9M/Q3-FY1822 Jan 2018, a zip file
Bliss GVS Pharma share news and announcements
Newest first. Page 1 of 13.
Oct 2026
29 Oct · Results
15 Oct · Disclosure
1 Oct · Board meeting
Sep 2026
29 Sep · Management
28 Sep · Board meeting
Aug 2026
20 Aug · Meeting
Jul 2026
24 Jul · Management
24 Jul · Management
21 Jul · Updates
20 Jul · Public Announcement-Open Offer
15 Jul · Meeting
3 Jul · Management
3 Jul · Board meeting
Jun 2026
23 Jun · Corporate action
23 Jun · Meeting
2 Jun · Public Announcement-Open Offer
May 2026
25 May · Public Announcement-Open Offer
How the price met the news
The latest 30. The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 29 Sep 2026Board or managers changeddown 3.63%−3.0 pts vs Nifty 500market median 0.0% · five sessions −8.3% (−8.2 pts vs Nifty 500) · volume 1.2× usual · The announcement
- 13 Aug 2026Resultsup 4.99%+5.1 pts vs Nifty 500market median −0.7% · five sessions +17.2% (+18.4 pts vs Nifty 500) · volume 2.9× usual · The announcement
- 27 Jul 2026Board or managers changeddown 1.12%−2.2 pts vs Nifty 500market median 0.0% · five sessions +0.2% (−2.2 pts vs Nifty 500) · volume 0.4× usual · The announcement
- 6 Jul 2026Board or managers changeddown 3.07%−3.6 pts vs Nifty 500market median 0.0% · five sessions +3.6% (+3.4 pts vs Nifty 500) · volume 0.5× usual · The announcement
- 13 May 2026Resultsup 2.10%+1.8 pts vs Nifty 500market median −0.7% · five sessions +3.3% (+2.3 pts vs Nifty 500) · volume 2.5× usual · delivery −9.6 pts against usual · The announcement
- 9 Apr 2026Credit ratingup 0.62%+1.1 pts vs Nifty 500market median 0.0% · five sessions +2.5% (+0.2 pts vs Nifty 500) · volume 1.5× usual · delivery −4.0 pts against usual · The announcement
- 11 Feb 2026Board or managers changedup 2.96%+2.8 pts vs Nifty 500market median 0.0% · five sessions +11.1% (+12.0 pts vs Nifty 500) · volume 3.2× usual · delivery −2.1 pts against usual · The announcement
- 10 Feb 2026Dividendup 2.20%+1.9 pts vs Nifty 500market median 0.0% · five sessions +9.0% (+9.9 pts vs Nifty 500) · volume 3.8× usual · delivery −4.7 pts against usual · The announcement
- 7 Nov 2025Resultsdown 15.84%−15.9 pts vs Nifty 500market median −0.7% · five sessions +10.2% (+8.9 pts vs Nifty 500) · volume 12.4× usual · delivery −13.9 pts against usual · The announcement
- 7 Nov 2025Board or managers changeddown 15.84%−15.9 pts vs Nifty 500market median 0.0% · five sessions +10.2% (+8.9 pts vs Nifty 500) · volume 12.4× usual · delivery −13.9 pts against usual · The announcement
20 earlier announcements
- 4 Sep 2025Credit ratingdown 1.54%−1.3 pts vs Nifty 500market median 0.0% · five sessions −3.8% (−4.7 pts vs Nifty 500) · volume 0.3× usual · delivery +13.0 pts against usual · The announcement
- 30 Jul 2025Resultsup 17.78%+17.7 pts vs Nifty 500market median −0.7% · five sessions +15.2% (+16.1 pts vs Nifty 500) · volume 45.1× usual · delivery −28.8 pts against usual · The announcement
- 13 May 2025Resultsdown 0.19%+0.5 pts vs Nifty 500market median −0.7% · five sessions +4.2% (+2.6 pts vs Nifty 500) · volume 1.9× usual · delivery −4.4 pts against usual · The announcement
- 13 May 2025Dividenddown 0.19%+0.5 pts vs Nifty 500market median 0.0% · five sessions +4.2% (+2.6 pts vs Nifty 500) · volume 1.9× usual · delivery −4.4 pts against usual · The announcement
- 28 Mar 2025Board or managers changeddown 1.03%−0.7 pts vs Nifty 500market median 0.0% · five sessions +1.2% (+4.0 pts vs Nifty 500) · volume 0.8× usual · delivery +2.8 pts against usual · The announcement
- 17 Jan 2025Board or managers changeddown 0.15%0.0 pts vs Nifty 500market median 0.0% · five sessions +2.0% (+2.8 pts vs Nifty 500) · volume 0.4× usual · delivery −0.5 pts against usual · The announcement
- 20 Jun 2024Credit ratingup 0.86%+0.5 pts vs Nifty 500market median 0.0% · five sessions +0.7% (−0.3 pts vs Nifty 500) · volume 1.1× usual · delivery −5.6 pts against usual · The announcement
- 3 May 2024Dividenddown 8.00%−7.4 pts vs Nifty 500market median 0.0% · five sessions −14.8% (−11.3 pts vs Nifty 500) · volume 4.5× usual · delivery −6.6 pts against usual · The announcement
- 2 Aug 2023Resultsdown 7.58%−6.5 pts vs Nifty 500market median −0.7% · five sessions −3.1% (−2.5 pts vs Nifty 500) · volume 1.7× usual · delivery −5.0 pts against usual · The announcement
- 12 May 2023Dividenddown 9.37%−9.3 pts vs Nifty 500market median 0.0% · five sessions −12.5% (−11.7 pts vs Nifty 500) · volume 3.8× usual · delivery −7.1 pts against usual · The announcement
- 10 Apr 2023Credit ratingdown 0.13%−0.3 pts vs Nifty 500market median 0.0% · five sessions −0.5% (−1.5 pts vs Nifty 500) · volume 0.4× usual · delivery −3.2 pts against usual · The announcement
- 3 Jun 2022Board or managers changeddown 0.56%+0.1 pts vs Nifty 500market median 0.0% · five sessions +2.8% (+4.1 pts vs Nifty 500) · volume 2.2× usual · delivery −0.5 pts against usual · The announcement
- 2 May 2022Dividenddown 1.92%−1.6 pts vs Nifty 500market median 0.0% · five sessions −7.0% (−1.6 pts vs Nifty 500) · volume 1.1× usual · delivery −18.4 pts against usual · The announcement
- 12 Jan 2022Credit ratingdown 0.10%−1.0 pts vs Nifty 500market median 0.0% · five sessions +1.4% (+1.1 pts vs Nifty 500) · volume 0.4× usual · delivery +5.1 pts against usual · The announcement
- 1 Nov 2021Resultsdown 2.75%−4.2 pts vs Nifty 500market median −0.7% · five sessions −5.6% (−8.5 pts vs Nifty 500) · volume 1.1× usual · delivery −20.2 pts against usual · The announcement
- 2 Aug 2021Resultsup 17.35%+16.5 pts vs Nifty 500market median −0.7% · five sessions +11.3% (+9.2 pts vs Nifty 500) · volume 33.7× usual · delivery −31.9 pts against usual · The announcement
- 12 May 2021Dividenddown 9.06%−8.2 pts vs Nifty 500market median 0.0% · five sessions −14.1% (−15.4 pts vs Nifty 500) · volume 2.3× usual · delivery −2.9 pts against usual · The announcement
- 14 Jan 2021Credit ratingdown 0.31%−0.6 pts vs Nifty 500market median 0.0% · five sessions −3.4% (−3.7 pts vs Nifty 500) · volume 0.6× usual · delivery +9.5 pts against usual · The announcement
- 17 Jun 2020Dividenddown 2.64%−2.5 pts vs Nifty 500market median 0.0% · five sessions −1.7% (−7.5 pts vs Nifty 500) · volume 1.8× usual · delivery −1.2 pts against usual · The announcement
- 8 Jun 2020Board or managers changedup 3.65%+3.4 pts vs Nifty 500market median 0.0% · five sessions +8.1% (+9.3 pts vs Nifty 500) · volume 2.6× usual · delivery −0.8 pts against usual · The announcement
Bliss GVS Pharma results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.